CEACAM6 and cholangiocarcinoma: Our study within cholangiocarcinoma cell lines demonstrated that CEACAM6 overexpressed cells were more chemoresistant to gemcitabine than mock-transfected cells and suppression of CEACAM6 expression by CEACAM6 siRNA increased chemosensitivity to gemcitabine.